PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations

Studies presented at the 2017 AACR annual meeting suggest that therapies which take advantage of the mutations in the IDH gene may be more effective than drugs that block it.

Cancer Currents: An NCI Cancer Research Blog